Despite impressive gains towards the Sustainable Development Goals (SDGs) in many communities worldwide, mothers, children and newborns are dying because they or their health provider cannot access quality-assured medicines needed for the provision of care. Essential medicines such as antibiotics, anesthetics, and antianemia medicines are often country-financed and frequently underfunded, making them unavailable to those who need them.
As a partner to over a dozen countries, the USAID Global Health Supply Chain Program-Procurement and Supply Management (GHSC-PSM) project is supporting governments and health system stakeholders to develop strategies and tools to engage, advocate and monitor allocated funding of MNCH medicines.
This document describes the complex challenges of increasing funding for quality essential medicines and experiences from various countries to inform other contexts.
